A股異動丨嬰童概念股集體走強,奧美醫療、麥趣爾10CM漲停,貝因美漲超6%
A股市場嬰童概念股集體走強,其中,潔雅股份、創源股份20CM漲停,久祺股份漲超13%,華立科技漲超12%,嘉必優漲超10%,奧美醫療、麥趣爾10CM漲停,貝因美漲超6%。消息上,近期地方生育利好政策持續出臺。海南省人民政府辦公廳印發《海南省提振和擴大消費三年行動方案》。其中提到,加大生育養育保障支持,出臺育兒補貼辦法。《遼寧省大力提振消費若幹舉措(徵求意見稿)》公開徵求意見,其中提到,加強生育養育保障,落實育兒補貼制度。廣州黃埔一社區出臺生育獎勵政策:生育三孩可一次性申領5萬元。另外,國家醫保局稱決定成立中國醫療保險研究會生育保險專業委員會。目前專委會籌備工作已就緒,現對社會各界徵集會員。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.